PS-Liposomes Based Immunotherapy (Ahead Therapeutics)

N/A

Report date: 2025/01/26 18:38:17

Base Information

Drug NamePS-Liposomes Based Immunotherapy (Ahead Therapeutics)
Drug Alias NamePhosphatidylserine-Liposome-Based Immunotherapy (Ahead Therapeutics)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAhead Therapeutics SL
China Registration ClassN/A

Develop Information

Active CompaniesAhead Therapeutics SL
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A